Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo
Keyword(s):
Keyword(s):
2020 ◽
Vol 18
(5)
◽
pp. 345-355
Keyword(s):
Keyword(s):
2018 ◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2020 ◽
Vol 162
◽
pp. 107-115
◽
Keyword(s):
2013 ◽
Vol 12
(3)
◽
pp. 286-294
◽
Keyword(s):